Beijing Normal University   Report issue

Academic/Hospital Phase 1
Founded: Beijing China (1902)

Organization Overview

First Clinical Trial
2015
NCT02799134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beijing Normal University | School of Brain and Cognitive Sciences, Beijing Nornal University

Active Ingredients

Drugs in Phase 1 Trials (2)

urea (1 trial)

vitamin c (1 trial)

Drugs in Other Trials (4)

bifidobacterium animalis (1 trial)

carbidopa (sinemet) (1 trial)

levodopa (larodopa) (1 trial)

oxytocin (syntocinon) (3 trials)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 5
  • # of Trial APIs: 6